The pharmaceutical industry has always been male-dominated.In this rapidly changing era, how do women have a place at the top of the wave?Entrepreneurship is a career without the concept of going to work rather than nine to five.Women Who are able to fight in this field need extraordinary wisdom and charm.
Today is the Goddess Festival. Let us count the outstanding female entrepreneurs in the Field of biomedicine in China today and pay tribute to these entrepreneurial goddesses! Note: Rank in no particular order, with the initials of the names.)
Cao Xiaochun Taige Medicine p>
Cao Xiaochun, co-founder of Tiger Pharmaceuticals. Director. Executive Vice President. Board Secretary. General Manager of Simer Pharmaceuticals. General Manager of Wangji Health. As co-founder and principal management of the company To help the president of Tiger Pharmaceuticals manage the overall affairs of Tiger Pharmaceutical Group and manage the Group's human resources. Administration.Government affairs.PR.CSR and other functional departments. Technology Co., Ltd. Daily work. She graduated from Zhejiang University of Traditional Chinese Medicine, majoring in medicine, Zhejiang University School of Pharmacy, Master of Pharmacy, licensed pharmacist, senior engineer.
Du Ying Ding Pharmaceutical
Du Ying, Chairman of the Board of Ding Pharmaceutical (Shanghai) Co., Ltd. Prior to Ding Ding, Du Ying worked as a general manager of medical investment at Sequoia Capital China. From 2001 to 2011, he was the founder and CEO of Hutchison Whampoa Pharmaceuticals. Graduated from the University of Cincinnati with a degree in biochemistry. p>
Fan Minhua Puli Pharmaceuticals
Fan Minhua, Chairman, Puli Pharmaceuticals. General Manager.Puli Pharmaceutical "Desloratadine Dry Suspension and Preparation Method"."A Desloratadine Dispersible Tablet And its Preparation". "A Trimebutine Maleate Tablet and the Preparation Method". The inventor of the invention patent such as "Trimebutine Maleate Dry Suspension and Preparation Method" chaired the FDA Of the products of Puli Pharmaceutical, ganciclov Ir sodium lyophilized powder for injection and API.CGMP (GMP) certification by the European Union and WHO.Ms. Fan Minhua is also a master's tutor of China Pharmaceutical University.
Feng Yuxia, Zhao Yanxin
Feng Yuxia, Chairman of Zhaoyan New Drugs, Pharmacology. Toxicology research expert, mainly engaged in preclinical safety evaluation of drugs. Under her leadership, Zhao Yan is mainly in Jiangsu Province. National and international pharmaceutical companies and research The organization provides a personalization program including R&D project design. Drug screening. Pharmacodynamic studies. Pharmacodynamic studies. Safety evaluation and clinical trial as well as registration service outsourcing services. He graduated from the Academy of Military Medical Sciences of the Chinese People's Liberation Army with a Master's degree in Pharmacology.
Huang Chunying TOT Pharmaceutical
Huang Chunying, East General Manager of Peony Pharmaceutical, graduated from the Department of Pharmacy, Taipei Medical University. TOT Pharmaceutical Co., Ltd. was founded in July 2010, is a professional engaged In anti-tumor drug research and development. High-tech enterprises in production and marketing, the company's products include monoclonal antibodies and antibody-conjugated drugs. Oncolytic virus products and special anti-cancer drugs, etc.
Lei Jufang Zangqizheng Pharmaceutical
Lei Jufang, current chairman of Tibet General Manager of Qizheng Tibetan Medicine Co., Ltd. Graduated from Xi'an Jiaotong University in 1977 The Bachelor of Vacuum Physics, Senior Engineer. Launched in the 1990s, Lei Jufang chose to develop in the Tibetan Plateau at an average altitude of 4000 meters above the Tibetan Plateau, spared no effort to promote the modernization of traditional medicine, for the development of Ethnic medicine to run the call, leading Tibetan medicine in the Chinese pharmaceutical market has a place.
Li Tan (first from left) graduated from the Department of Chemistry of Sichuan University in July 1987. He worked in the Education Department of the Department of Petrochemical Industry of Anhui Province in August 1987. He entered Chongqing Tongda in July 1992 and served as the vice president. Engineer. Deputy General Manager, he has been involved in Haipu Rui Industrial since April 1998. He is currently a director of the Company. Deputy General Manager, Executive Director of Jintiantu Technology. Director of Doppler Industries. Chairman of Dopson Biotechnology.
Liao Guojuan Jin Weizhi
Dr. Liao Guojuan, co-founder and CEO of GENEWIZ, National “Thousand Talents Program”. He completed his postdoctoral studies in biochemistry and cell biology at Columbia University.In 1999, with the implementation Of the Human Genome Project, Dr. Liao Guojuan and Dr. Sun Zhongping co-founded GENEWIZ in the United States. The company is now one of the world's leading providers of genomics technology services, operating 15 genomes in multiple countries around the world. Laboratory, providing research services to tens of thousands of global researchers including 30 Nobel laureates.
Liao Xiaoling Immune-Onc Therapeutics
Dr. Liao Xiaotong, co-founder of Immune-Onc Therapeutics. President and CEO. He graduated from Peking University with a major in biochemistry and was selected to study in the United States through CUSBEA. He received his Ph. D. from Brandeis Brandeis University and studied under Michael Rosbash, one of the Nobel Prize winners in physiology and medicine in 2017. worked in the US Genentech, a biotechnology company, has been in charge of early drug development for nearly 14 years.
Annan Pharmaceuticals, Tang Nanshan
Dr. Tang Nanshan, currently CEO of Ansun Biopharmaceuticals, is a joint venture of Yuanming Capital and Fang Yuan Fund to develop a new generation of drugs against influenza and parainfluenza viruses, whose products have been accredited by the FDA as "Breakthrough Therapies". A native of Wu Jiang, who graduated from Harvard University in early years, obtained biochemistry and Doctor of Philosophy, ranked first among the 25 well-known American Chinese in Forbes in 2008. She is a woman active in the biopharmaceutical industry today and founder of Houston's Tanox, which was acquired by Genentech in 2006 for $919 million. p>
Wang Xijuan Kangchen Pharmaceutical
Ms. Wang Xijuan, Chairman of Beijing Kangchen Pharmaceutical Co., Ltd. was a technician at Beijing Post and Telecommunications Hospital. Beijing Weilun Pharmaceutical General Manager of Development Company. Chairman of Beijing Rongsheng Pharmaceutical Technology Co., Ltd., etc. Now serves as Chairman of Kangchen Pharmaceutical. Director of Liaoning Kangchen. Chairman of Ren Investment. Executive director and manager of kang chen technology. Head of the Pharmaceutical Research Institute. Director of Sinopharm Kangchen et al.
Wu Youling Treth Pharmaceutical
Zhejiang Teresi Pharmaceutical Co., Ltd. President/Chairman, National Thousand Talents Program Specialist and South Taihu Elite Program Leaders, is a major new drug creation project of the Ministry of Science and Technology. National development and reform commission Analysis and identification of protein drugs. Process development and pharmaceutical research of monoclonal antibodies. There is a deep understanding of the regulatory registration of drugs, leading and participating in the first monoclonal antibody coupling in the United States. Development of the drug Brentuximab.
Xia Yu Kang Fang Biological
Xia Yu, co-founder of Zhongshan Kangfang Biology, is The current chairman, president and CEO of the company. He served in Bayer, Germany. PDL Biopharmaceuticals (now Abbott Laboratories), US-based CeleraGenomics and other European and American pharmaceutical companies, responsible for or involved in the preclinical study of several new drugs. , production process development of new antibody drugs, process amplification, technology conversion and GMP production of antibodies, and FDA clinical trial approval. Since his return to China in April 2008, Dr. Xia Yu has served as Senior Vice President of China-US Guanke Biotechnology Co., Ltd. and concurrently served as Director and General Manager of Taicang Guanke Bioanalytical Testing Co., Ltd.
Yang Yuqiu Biotechnology
Yang Wei, founder of Kaixin Bio, CEO. Graduated from Peking University in 2008. He was named the first 30 scientific medical students under the age of 30 in 2014 by Forbes magazine for the first use of CRISPR-Cas9 technology to modify the cell genome and lead eGenesis. One of the leading figures in the field (30 under 30). Kaixin Bio is a genetically edited organ transplant technology developer dedicated to using genetic editing techniques to obtain xenogeneic cells, tissues and organs that can be used for human transplantation, and to address the shortage of organ transplant donors. Problem.
Ye Yingli Pharmaceuticals
Ye Ying, Founder of Lipin Pharmaceutical ( Xiamen) Chairman of Co., Ltd. Ye Ying in 2013 Established Lipin Pharmaceutical Co., Ltd., introduced and cultivated a group of high-tech pharmaceutical talents in line with international standards, built an oral mucosal drug delivery technology platform with independent international patents, and a technology platform for slow and controlled release preparations that meets the requirements of industrial scale. Epilepsy in children.ADHD in children.Antiemetic drugs for elderly and children in cancer patients.
Zhang Renhua Ruikang Medicine
Zhang Renhua, born in 1966, college degree, pharmacist. He served as secretary of the General Branch of Yantaishan Hospital, general manager of Shandong Ruikang Pharmaceutical, general manager of Ruikang Distribution, and now serves as vice chairman and general manager of the company, Shandong Province NPC Deputies.
Zhao Ning, WuXi PharmaTech
Zhao Ning, currently a director Of WuXi AppTec. Vice President of Analytical Services and Principal Advisor of Analytical Services, during which he established a platform for integration from chemical Analysis to pharmaceutical analysis to bioanalysis and quality inspection of production.
Zheng Xiangling Zhengda Qingqing
Zheng Xiangling, President of Zhengda Pharmaceutical Group. Chairman of TANDBERG Pharmaceuticals. Zheng Xiangling is the wife of Xie Bing, chairman of China Biopharmaceutical. Zheng Xiangling was the executive director of China Biopharmaceutical in January 2005. On April 10, 2017, China Biopharma announced that Zheng Xiangling has been appointed as the executive director of the company. Vice Chairman of the Board and a member of the Executive Board Committee. Zheng Xiangling holds approximately 1.863 billion shares of the company through its own interests and interests in Zhengda Centennial Group Co., Ltd. and Remarkable Industries Limited.
< p>Zhong Huijuanhaosen Biological
Huijuan Zhong, Han, Master, President of Jiangsu Haosen Pharmaceutical Group Co., Ltd.Excellent female entrepreneur in China. China's outstanding entrepreneurial women. Jiangsu outstanding private entrepreneurs. The red flag man of jiangsu province. Jiangsu's top ten outstanding young enterprises Home. Top Ten Environmental Entrepreneur of Jiangsu Province. The controlling shareholder of Haosen Pharmaceutical is the chairman. Executive Director and Founder.